&nbsp;

pdfWhite.png

Oct 2019

Document

pdfWhite1.png

Oct 2019

Document

pdfWhite2.png

Oct 2019

Document

pdfWhite3.png

Oct 2019

Carte des voies pathologiques du cancer de l’endomètre

Carte des voies pathologiques du cancer de l’œsophage

Carte des voies pathologiques du cancer oropharyngien

Carte des voies pathologiques du sarcome des tissus mous

Regimen

CRBPETOP+ATEZ

Cancer Type:

Lung,

Small Cell

Intent: Palliative

Funding:

New Drug Funding Program

Atezolizumab - In Combination with Etoposide and Platinum for Extensive-Stage Small Cell Lung Cancer

New Drug Funding Program

Atezolizumab - In Combination with Etoposide and Platinum for Extensive-Stage Small Cell Lung Cancer

Drugs Used:

atezolizumab,

atezolizumab (subcut),

CARBOplatin,

etoposide

Quick Link(s):

Regimen Monograph

May 2025

Regimen

CRBPETOP(PO)+ATEZ

Cancer Type:

Lung,

Small Cell

Intent: Palliative

Funding:

ODB - General Benefit

etoposide - oral capsules

New Drug Funding Program

Atezolizumab - In Combination with Etoposide and Platinum for Extensive-Stage Small Cell Lung Cancer

New Drug Funding Program

Atezolizumab - In Combination with Etoposide and Platinum for Extensive-Stage Small Cell Lung Cancer

Drugs Used:

atezolizumab,

atezolizumab (subcut),

CARBOplatin,

etoposide

Quick Link(s):

Regimen Monograph

May 2025

Regimen

CISPETOP(IND)

Cancer Type:

Gynecologic,

Gestational Trophoblastic Disease

Intent: Adjuvant, Curative

Drugs Used:

CISplatin,

etoposide

Quick Link(s):

Regimen Monograph

Nov 2019

Regimen

CRBPPACL+ATEZBEVA

Cancer Type:

Lung,

Non-Small Cell

Intent: Palliative

Drugs Used:

atezolizumab (Unfunded),

bevacizumab (Unfunded),

PACLitaxel,

CARBOplatin